Margaret Monckton appointed Chief Financial Officer of Great Ormond Street Hospital

29 Nov 2024, 11:51 a.m.

A lady with short brown hair, wearing a blue cardigan is smiling at the camera

Margaret Monckton has been appointed as Chief Financial Officer (CFO) for Great Ormond Street Hospital NHS Foundation Trust.

Margaret joins the hospital from the University of Nottingham where she has been Chief Financial Officer for the last eight years.

She said: “I’m excited to be joining Great Ormond Street Hospital to support the work of the staff providing the best possible care to their patients.

“My interests in education and research will fit in well at Great Ormond Street Hospital and I am eager to learn more about the breakthroughs and transformations that I know will be in the pipeline.”

Matthew Shaw, Chief Executive of Great Ormond Street Hospital, said: “We are delighted to welcome Margaret to the hospital. She brings a wealth of experience from across vital sectors, with a particular focus on education and research.

“She goes above and beyond in her roles to share her knowledge and expertise with colleagues and partners. I am greatly looking forward to working with her as she brings her vision and drive to Great Ormond Street Hospital.”

In addition to the University of Nottingham, Margaret has previously worked at Staffordshire University, Nottinghamshire Police, The National College for Leadership of Schools and Children’s Services and Boots.

She has also held a number non executive roles including being a governor for a further education college, the lead higher education sector pension scheme negotiator for UCEA and an independent member of the Officer for Students Audit Committee.

She is currently the Chair of the NOVA Education Trust and a Non Executive Director at University Hospital North Midlands NHS Trust.

Margaret will take up her position on 6 January and will replace Lore Lippmann, the acting CFO.

New trial to support childhood survivors of brain tumours

Experts at Great Ormond Street Hospital have launched the first trial of its kind to support children’s cognitive development following treatment for a brain tumour.

Professor Waseem Qasim named in list of leading global health leaders

Professor Waseem Qasim, Consultant at GOSH and Professor of Cell and Gene Therapy at University College London has been named in TIME magazine’s 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

Alyssa Tapley named in list of leading global health leaders

GOSH patient, Alyssa Tapley, 17 from Leicester, has been named in TIME’S 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

GOSH joins partnership to boost early diagnosis and deliver better treatments

GOSH is partnering with LifeArc to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.